Wiktor Szymaski participant in KWF Research and Implementation grant
A KWF grant of 700k Eur was awarded to Bart Cornelissen (UMCG, main applicant) and Wiktor Szymanski (co applicant) for developing new medicines that can be activated with X-ray irradiation. This type of irradiation is typically used in cancer radiotherapy, where it can be precisely delivered to the tumors and damage DNA in their cells, leading to a therapeutic effect. In this project, Wiktor and Bart will combine this effect with pharmacotherapy, and use the same irradiation to also locally activate a chemotherapeutic drug for a synergistic action. Wiktor will be responsible for the chemistry part, developing new, efficient ways in which molecules can be selectively activated by photons of high energy, which can also be used in other therapeutic applications.
Original KWF announcement "Plaatselijke behandeling met stralingsgevoelige medicijnen"
Last modified: | 17 July 2023 10.00 a.m. |
More news
-
10 June 2024
Swarming around a skyscraper
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
21 May 2024
Results of 2024 University elections
The votes have been counted and the results of the University elections are in!